Stability of Protein Pharmaceuticals -

Stability of Protein Pharmaceuticals

Part B: In Vivo Pathways of Degradation and Strategies for Protein Stabilization

Tim J. Ahern, Mark C. Manning (Herausgeber)

Buch | Hardcover
328 Seiten
1992
Kluwer Academic/Plenum Publishers (Verlag)
978-0-306-44153-0 (ISBN)
213,99 inkl. MwSt
Part B explores protein degradation occuring in vivo during protein synthesis in cells, examines the isolation and purification of proteins, details protein use in organisms, and reviews techniques to enhance protein stability.

Improper Glycosylation and the Cellular Editing of Nascent Proteins; D.A. Cumming. Protein Aggregation In Vivo; R. Wetzel. Pathways of Intracellular Protein Degradation in Eukaryotic Cells; T.S. Olson, et al. Effects of Aging on Proteins; R.W. Gracy. Engineering Dramatic Increases in the Stability of Subtilisin; P.N. Bryan. Increased Stability of Mutant Forms of Yeast Cytochrome c; D.R. Hickey, et al. Introduction to Formulation of Protein Pharmaceuticals; M.A. Hanson, S.K.E. Rouan. PEG Modified Proteins; G.E. Francis, et al. Stabilization of Protein Structure by Solvent Additives; S.N. Timasheff. Heat-Shock Proteins and their Potential Uses for Pharmaceutical Protein Production in Microorganisms; J.M. McCoy. Index.

Erscheint lt. Verlag 30.11.1992
Reihe/Serie Pharmaceutical Biotechnology ; 3
Zusatzinfo XXVI, 328 p.
Verlagsort New York
Sprache englisch
Maße 156 x 234 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pharmazie PTA / PKA
Naturwissenschaften Biologie Biochemie
ISBN-10 0-306-44153-5 / 0306441535
ISBN-13 978-0-306-44153-0 / 9780306441530
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich